{"id":15357,"date":"2025-09-16T19:50:21","date_gmt":"2025-09-16T19:50:21","guid":{"rendered":"https:\/\/nmsconsulting.com\/?p=15357"},"modified":"2025-09-17T15:18:30","modified_gmt":"2025-09-17T15:18:30","slug":"pharmaceutical-ma-integration-savings-playbook-2025","status":"publish","type":"post","link":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/","title":{"rendered":"Pharmaceutical M&#038;A Integration Savings Playbook 2025: R&#038;D, Manufacturing, Quality, Supply Chain, Commercial and SG&#038;A"},"content":{"rendered":"<!--themify_builder_content-->\n<div id=\"themify_builder_content-15357\" data-postid=\"15357\" class=\"themify_builder_content themify_builder_content-15357 themify_builder tf_clear\">\n                    <div  data-lazy=\"1\" class=\"module_row themify_builder_row tb_s8ij662 tb_first tf_w\">\n                        <div class=\"row_inner col_align_top tb_col_count_1 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column col-full tb_7jtx600 first\">\n                    <!-- module image -->\n<div  class=\"module module-image tb_qs5q040 image-center   tf_mw\" data-lazy=\"1\">\n        <div class=\"image-wrap tf_rel tf_mw\">\n            <img decoding=\"async\" src=\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA-1024x683-950x600.jpg\" width=\"950\" height=\"600\" class=\"wp-post-image wp-image-15360\" title=\"Pharmaceutical M&amp;A Integration Savings Playbook 2025: R&amp;D, Manufacturing, Quality, Supply Chain, Commercial and SG&amp;A\" alt=\"Pharmaceutical M&amp;A Integration Savings Playbook 2025: R&amp;D, Manufacturing, Quality, Supply Chain, Commercial and SG&amp;A\">    \n        <\/div>\n    <!-- \/image-wrap -->\n    \n        <div class=\"image-content\">\n                        <div class=\"image-caption tb_text_wrap\">\n            Pharmaceutical M&#038;A Integration Savings Playbook 2025: R&#038;D, Manufacturing, Quality, Supply Chain, Commercial and SG&#038;A        <\/div>\n        <!-- \/image-caption -->\n            <\/div>\n    <!-- \/image-content -->\n        <\/div>\n<!-- \/module image --><!-- module text -->\n<div  class=\"module module-text tb_x7zk680   \" data-lazy=\"1\">\n        <div  class=\"tb_text_wrap\">\n        <p><!-- ========================================================= NMS Consulting \u2014 Pharmaceutical M&A Integration Savings Playbook 2025 Clean, snippet-friendly HTML with hardened CTAs and linked sources Brand colors: #8f0020 (maroon) on white ========================================================= --><\/p>\n<style>\n  :root{--brand:#8f0020;--ink:#1a1a1a;--wash:#faf7f8}<br \/>\n  .nms-exec{color:var(--ink);font-family:system-ui,-apple-system,Segoe UI,Roboto,Arial,sans-serif;line-height:1.6}<br \/>\n  .nms-exec .container{max-width:980px;margin:0 auto;padding:24px}<br \/>\n  \/* Meta band (no H1; theme prints title) *\/<br \/>\n  .hero-band{background:var(--wash);border-top:6px solid var(--brand);padding:18px 20px;border-radius:14px;margin:0 0 20px;box-shadow:0 1px 3px rgba(0,0,0,.05)}<br \/>\n  .byline{font-size:.95rem;color:#555;margin:.25rem 0 0}<br \/>\n  .dates{font-size:.9rem;color:#666;margin:.1rem 0 0}<br \/>\n  \/* Reusable callouts *\/<br \/>\n  .answer-box{background:#fff;border:2px solid var(--brand);border-radius:14px;padding:14px 16px}<br \/>\n  .note{background:var(--wash);border:2px solid var(--brand);border-radius:14px;padding:12px 14px;margin:18px 0}<br \/>\n  .box{background:#fff;border:2px solid var(--brand);border-radius:14px;padding:14px 16px;box-shadow:0 1px 2px rgba(0,0,0,.04);margin:18px 0}<br \/>\n  \/* Headings *\/<br \/>\n  h2{font-size:1.45rem;line-height:1.25;margin:1.5em 0 .6em}<br \/>\n  h3{font-size:1.18rem;line-height:1.35;margin:1.1em 0 .45em}<br \/>\n  \/* KPI \/ evidence table *\/<br \/>\n  .pro-table{width:100%;border-collapse:separate;border-spacing:0;margin:.6em 0 1.2em;table-layout:fixed}<br \/>\n  .pro-table th,.pro-table td{border:1px solid #ddd;padding:10px 12px;text-align:left;vertical-align:top}<br \/>\n  .pro-table thead th{background:var(--wash)}<br \/>\n  .pro-table caption{caption-side:top;font-weight:700;margin:.2em 0 .5em}<br \/>\n  .pro-table col.col-find{width:48%}.pro-table col.col-fig{width:22%}.pro-table col.col-src{width:30%}<br \/>\n  \/* Stat pills *\/<br \/>\n  .stat-grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(220px,1fr));gap:12px;margin:14px 0}<br \/>\n  .stat{border:1px solid #e6e6e6;border-radius:14px;padding:14px 16px;background:#fff;box-shadow:0 1px 3px rgba(0,0,0,.05)}<br \/>\n  .stat .value{font-size:1.35rem;font-weight:800;color:var(--brand);letter-spacing:-.01em;font-variant-numeric:tabular-nums}<br \/>\n  .stat .label{font-size:.95rem;color:#444}<br \/>\n  \/* Links and hardened CTAs *\/<br \/>\n  a{color:var(--brand);text-decoration-thickness:1.5px;text-underline-offset:3px}<br \/>\n  a:hover{opacity:.94}<br \/>\n  a.cta,a.cta:link,a.cta:visited,.wp-element-button.cta,.wp-block-button__link.cta{<br \/>\n    background-color:var(--brand)!important;border:2px solid var(--brand)!important;color:#fff!important;<br \/>\n    display:inline-block!important;padding:12px 18px!important;text-decoration:none!important;border-radius:12px!important;<br \/>\n    font-weight:700!important;line-height:1.2!important;box-shadow:0 1px 3px rgba(0,0,0,.08)!important<br \/>\n  }<br \/>\n  a.cta:hover{opacity:.95!important}<br \/>\n  .sources li{word-break:break-word}<br \/>\n  @media (max-width:640px){.nms-exec .container{padding:18px}h2{font-size:1.35rem}}<br \/>\n<\/style>\n<p><!-- BlogPosting schema --><br \/>\n<script type=\"application\/ld+json\">\n{\n  \"@context\":\"https:\/\/schema.org\",\n  \"@type\":\"BlogPosting\",\n  \"headline\":\"Pharmaceutical M&A Integration Savings Playbook 2025: R&D, Manufacturing, Quality, Supply Chain, Commercial and SG&A\",\n  \"description\":\"A plain-English playbook to capture pharmaceutical M&A synergies across R&D, manufacturing and quality, supply chain, commercial and SG&A. Includes linked benchmarks, regulatory touchpoints and a 30\/60\/90 plan.\",\n  \"datePublished\":\"2025-09-16\",\n  \"dateModified\":\"2025-09-16\",\n  \"author\":{\"@type\":\"Person\",\"name\":\"Aykut Cakir\"},\n  \"publisher\":{\"@type\":\"Corporation\",\"name\":\"NMS Consulting\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2020\/05\/NMS-Logo.png\"}},\n  \"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nmsconsulting.com\/insights\/pharma-ma-integration-savings-playbook-2025\/\"}\n}\n<\/script><\/p>\n<p><!-- Optional FAQ schema for PAA-style Q&A --><br \/>\n<script type=\"application\/ld+json\">\n{\n \"@context\":\"https:\/\/schema.org\",\n \"@type\":\"FAQPage\",\n \"mainEntity\":[\n   {\"@type\":\"Question\",\"name\":\"What is pharmaceutical M&A integration?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It is the work that turns a deal into savings and growth without disrupting quality or supply. It links R&D, manufacturing, quality, supply chain, commercial, and SG&A to a tracked value tree and a time-boxed plan.\"}},\n   {\"@type\":\"Question\",\"name\":\"Why focus on quality and supply first?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Regulated products must maintain GMP, pharmacovigilance, and traceability. Guardrails such as change control and quality system harmonization prevent shortages, findings, or consent decrees while savings take hold.\"}}\n ]\n}\n<\/script><\/p>\n<div class=\"nms-exec\">\n<div class=\"container\">\n<section class=\"hero-band\" aria-label=\"Meta\">\n<p class=\"byline\">Author: Aykut Cakir<\/p>\n<p class=\"dates\">Published: <time datetime=\"2025-09-16\">2025-09-16<\/time> \u2022 Updated: <time datetime=\"2025-09-16\">2025-09-16<\/time><\/p>\n<\/section>\n<p>  <!-- Quick answer (40\u201360 words) --><\/p>\n<section class=\"answer-box\" aria-label=\"Quick answer\"><strong>Quick answer:<\/strong><br \/>\n    Pharmaceutical M&#038;A integration savings come from a tracked value tree across R&amp;D, manufacturing and quality, supply chain, commercial, and SG&amp;A. Keep patients, quality, and supply stable while executing no-regret moves and a 30\/60\/90 plan. Proven benchmarks show cost synergy targets often in high single digits to teens of target revenue, with pharma outliers higher.<br \/>\n  <\/section>\n<p style=\"margin:.8rem 0 1.1rem;\">Want a CFO-ready value tree and day-one guardrails? <a class=\"cta\" href=\"https:\/\/nmsconsulting.com\/contact\/\">Talk to a consultant<\/a><\/p>\n<h2 id=\"why-now\">Why Deals Need A Tight Integration Plan In 2025<\/h2>\n<div class=\"stat-grid\" aria-label=\"Headline stats\">\n<div class=\"stat\">\n<div class=\"value\">12.2% TSR<\/div>\n<div class=\"label\">Frequent healthcare acquirers outperformed inactive peers over 2012\u20132022 <a href=\"https:\/\/www.bain.com\/insights\/healthcare-and-life-sciences-m-and-a-report-2025\/\" rel=\"noopener\">source<\/a>.<\/div>\n<\/div>\n<div class=\"stat\">\n<div class=\"value\">6%\u201310%<\/div>\n<div class=\"label\">Typical announced cost synergies as % of target revenue across industries <a href=\"https:\/\/www.lek.com\/insights\/pe\/us\/ei\/keys-unlocking-merger-value-cost-synergies\" rel=\"noopener\">source<\/a>.<\/div>\n<\/div>\n<div class=\"stat\">\n<div class=\"value\">~20%<\/div>\n<div class=\"label\">Average pharma cost synergy as % of target revenue in historic deals <a href=\"https:\/\/www.ey.com\/en_cn\/insights\/strategy-transactions\/how-life-sciences-executives-can-achieve-m-a-synergies\" rel=\"noopener\">source<\/a>.<\/div>\n<\/div>\n<div class=\"stat\">\n<div class=\"value\">DSCSA live<\/div>\n<div class=\"label\">Package-level traceability obligations are active in the U.S. supply chain <a href=\"https:\/\/www.fda.gov\/drugs\/drug-supply-chain-integrity\/drug-supply-chain-security-act-dscsa\" rel=\"noopener\">source<\/a>.<\/div>\n<\/div>\n<\/div>\n<p>  <!-- Evidence table --><\/p>\n<section class=\"note\" aria-label=\"Key numbers\">\n<table class=\"pro-table\">\n<caption><strong>Key Numbers And References<\/strong><\/caption>\n<colgroup>\n<col class=\"col-find\">\n<col class=\"col-fig\">\n<col class=\"col-src\"><\/colgroup>\n<thead>\n<tr>\n<th>Finding<\/th>\n<th>Figure<\/th>\n<th>Source<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Frequent acquirers outperform in healthcare and life sciences<\/td>\n<td>12.2% TSR vs 0.3%<\/td>\n<td><a href=\"https:\/\/www.bain.com\/insights\/healthcare-and-life-sciences-m-and-a-report-2025\/\" rel=\"noopener\">Bain, 2025<\/a><\/td>\n<\/tr>\n<tr>\n<td>Typical announced cost synergy range across industries<\/td>\n<td>6%\u201310% of target revenue<\/td>\n<td><a href=\"https:\/\/www.lek.com\/insights\/pe\/us\/ei\/keys-unlocking-merger-value-cost-synergies\" rel=\"noopener\">L.E.K., 2024<\/a><\/td>\n<\/tr>\n<tr>\n<td>Historic pharma cost synergy benchmark<\/td>\n<td>~20% of target revenue<\/td>\n<td><a href=\"https:\/\/www.ey.com\/en_cn\/insights\/strategy-transactions\/how-life-sciences-executives-can-achieve-m-a-synergies\" rel=\"noopener\">EY analysis<\/a><\/td>\n<\/tr>\n<tr>\n<td>Revenue synergies take longer than cost synergies<\/td>\n<td>Slower capture curve<\/td>\n<td><a href=\"https:\/\/www.mckinsey.com\/~\/media\/McKinsey\/Business%20Functions\/Marketing%20and%20Sales\/Our%20Insights\/Seven%20rules%20to%20crack%20the%20code%20on%20revenue%20synergies%20in%20MA\/Seven-rules-to-crack-the-code-on-revenue-synergies-in-M-and-A.pdf\" rel=\"noopener\">McKinsey<\/a><\/td>\n<\/tr>\n<tr>\n<td>Quality maturity and business continuity matter to supply<\/td>\n<td>FDA QMM and shortage factors<\/td>\n<td><a href=\"https:\/\/www.fda.gov\/media\/171705\/download\" rel=\"noopener\">FDA QMM<\/a>; <a href=\"https:\/\/www.fda.gov\/media\/131130\/download?attachment=\" rel=\"noopener\">FDA Drug Shortages<\/a><\/td>\n<\/tr>\n<tr>\n<td>Regulatory steps during integration<\/td>\n<td>MA transfer and PV continuity<\/td>\n<td><a href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/transfer-marketing-authorisation-questions-answers\" rel=\"noopener\">EMA MA Transfer<\/a>; <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10239279\/\" rel=\"noopener\">PV continuity paper<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/section>\n<h2 id=\"playbook\">30\/60\/90 Integration Playbook<\/h2>\n<h3>First 30 Days: Stabilize Quality And Supply<\/h3>\n<ul>\n<li>Stand up an Integration Management Office with a single value tree and KPI pack tied to finance.<\/li>\n<li>Freeze high-risk changes until Quality signs off; harmonize change control and deviation workflows <a href=\"https:\/\/www.outsourcedpharma.com\/doc\/integrating-quality-processes-and-documentation-after-a-merger-0001\" rel=\"noopener\">reference<\/a>.<\/li>\n<li>Traceability and partner validation under DSCSA; confirm Authorized Trading Partners and product identifiers <a href=\"https:\/\/www.fda.gov\/drugs\/drug-supply-chain-integrity\/drug-supply-chain-security-act-dscsa\" rel=\"noopener\">reference<\/a>.<\/li>\n<\/ul>\n<h3>Days 31\u201360: Launch No-Regret Savings<\/h3>\n<ul>\n<li>Procurement: unify rate cards for CMOs, CROs, and key materials; move to preferred vendors with quality agreements aligned to CGMP <a href=\"https:\/\/www.mastercontrol.com\/gxp-lifeline\/5-key-questions-about-quality-agreements\/\" rel=\"noopener\">reference<\/a>.<\/li>\n<li>SG&amp;A: consolidate duplicative corporate services and harmonize tooling; typical cost categories align with industry ranges <a href=\"https:\/\/www.lek.com\/sites\/default\/files\/insights\/pdf-attachments\/keys-cost-synergies.pdf\" rel=\"noopener\">reference<\/a>.<\/li>\n<li>Commercial: build unified territory maps and rules of engagement; expect revenue synergy to lag cost synergy <a href=\"https:\/\/www.mckinsey.com\/~\/media\/McKinsey\/Business%20Functions\/Marketing%20and%20Sales\/Our%20Insights\/Seven%20rules%20to%20crack%20the%20code%20on%20revenue%20synergies%20in%20MA\/Seven-rules-to-crack-the-code-on-revenue-synergies-in-M-and-A.pdf\" rel=\"noopener\">reference<\/a>.<\/li>\n<\/ul>\n<h3>Days 61\u201390: Lock In Structure And Growth<\/h3>\n<ul>\n<li>R&amp;D: rationalize the project portfolio; cut duplicate studies and align governance gates; maintain GLP\/GCP controls <a href=\"https:\/\/www.apislabor.org\/our-blog\/the-critical-role-of-technical-due-diligence-in-pharmaceutical-mergers\" rel=\"noopener\">reference<\/a>.<\/li>\n<li>Manufacturing and Quality: footprint and tech-transfer roadmap; pre-approve validation plans with QA; audit critical CMOs <a href=\"https:\/\/www.propharmagroup.com\/thought-leadership\/giving-quality-assurance-respect-during-a-post-merger-integration\" rel=\"noopener\">reference<\/a>.<\/li>\n<li>Regulatory and PV: execute Marketing Authorisation transfers and maintain Qualified Person for Pharmacovigilance coverage where required <a href=\"https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/european-medicines-agency-post-authorisation-procedural-advice-users-centralised-procedure_en.pdf\" rel=\"noopener\">reference<\/a>.<\/li>\n<\/ul>\n<h2 id=\"levers\">Savings Levers By Function<\/h2>\n<h3>R&amp;D<\/h3>\n<ul>\n<li>Portfolio focus and study start cycle-time reduction; harmonize data standards and eTMF; rationalize external spend with CRO panels.<\/li>\n<\/ul>\n<h3>Manufacturing And Quality<\/h3>\n<ul>\n<li>Network optimization, batch size and campaign planning, validation consolidation; common QMS and training; evergreen shortage prevention using business continuity practices <a href=\"https:\/\/www.fda.gov\/media\/171705\/download\" rel=\"noopener\">reference<\/a>.<\/li>\n<\/ul>\n<h3>Supply Chain<\/h3>\n<ul>\n<li>API and critical material dual-sourcing; integrated S&amp;OP; serialization and partner onboarding per DSCSA <a href=\"https:\/\/koerber-supplychain.com\/about-us\/blog\/dscsa-enforcement-has-begun\/\" rel=\"noopener\">reference<\/a>.<\/li>\n<\/ul>\n<h3>Commercial<\/h3>\n<ul>\n<li>Unified account coverage, sample and compliance guardrails, CRM harmonization; salesforce integration drives growth when done early <a href=\"https:\/\/www.bain.com\/client-results\/salesforce-integration-generates-m-and-a-success-in-healthcare\/\" rel=\"noopener\">reference<\/a>.<\/li>\n<\/ul>\n<h3>SG&amp;A<\/h3>\n<ul>\n<li>Shared services for finance, HR, legal, and procurement; tooling rationalization; benchmarks show sizable finance overlap in some pharma deals <a href=\"https:\/\/www.mckinsey.com\/capabilities\/strategy-and-corporate-finance\/our-insights\/a-winning-formula-for-deal-synergies\" rel=\"noopener\">reference<\/a>.<\/li>\n<\/ul>\n<div class=\"box\" aria-label=\"CTA\">\n    <strong>Want a deal-specific savings blueprint?<\/strong> We can build a value tree, guardrail pack, and weekly tracking that finance trusts.<br \/>\n    <br><a class=\"cta\" href=\"https:\/\/nmsconsulting.com\/contact\/\">Request a synergy workshop<\/a>\n  <\/div>\n<h2 id=\"related\">Related Reading<\/h2>\n<ul>\n<li><a href=\"https:\/\/nmsconsulting.com\/mergers-acquisitions\/\">M&amp;A Services<\/a><\/li>\n<li><a href=\"https:\/\/nmsconsulting.com\/post-merger-integration\/\">Post Merger Integration<\/a><\/li>\n<li><a href=\"https:\/\/nmsconsulting.com\/business-transformation\/\">Business Transformation<\/a><\/li>\n<li><a href=\"https:\/\/nmsconsulting.com\/pharmacology-ma-synergy-capture-guide-2025\/\">Pharmacology M&amp;A Synergy Capture Guide 2025<\/a><\/li>\n<li><a href=\"https:\/\/nmsconsulting.com\/change-management\/\">Change Management<\/a><\/li>\n<\/ul>\n<h2 id=\"sources\">Sources<\/h2>\n<ul class=\"sources\">\n<li>Bain. Healthcare and Life Sciences M&amp;A Report 2025. https:\/\/www.bain.com\/insights\/healthcare-and-life-sciences-m-and-a-report-2025\/<\/li>\n<li>L.E.K. Keys to Unlocking Merger Value: Cost Synergies. https:\/\/www.lek.com\/insights\/pe\/us\/ei\/keys-unlocking-merger-value-cost-synergies<\/li>\n<li>EY. How life sciences executives can achieve M&amp;A synergies. https:\/\/www.ey.com\/en_cn\/insights\/strategy-transactions\/how-life-sciences-executives-can-achieve-m-a-synergies<\/li>\n<li>McKinsey. Seven rules to crack the code on revenue synergies in M&amp;A. https:\/\/www.mckinsey.com\/~\/media\/McKinsey\/Business%20Functions\/Marketing%20and%20Sales\/Our%20Insights\/Seven%20rules%20to%20crack%20the%20code%20on%20revenue%20synergies%20in%20MA\/Seven-rules-to-crack-the-code-on-revenue-synergies-in-M-and-A.pdf<\/li>\n<li>FDA. Drug Supply Chain Security Act (DSCSA). https:\/\/www.fda.gov\/drugs\/drug-supply-chain-integrity\/drug-supply-chain-security-act-dscsa<\/li>\n<li>FDA. Quality Management Maturity. https:\/\/www.fda.gov\/media\/171705\/download<\/li>\n<li>FDA. Drug Shortages: Root Causes and Potential Solutions. https:\/\/www.fda.gov\/media\/131130\/download<\/li>\n<li>EMA. Transfer of Marketing Authorisation: Q&amp;A. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/transfer-marketing-authorisation-questions-answers<\/li>\n<li>ProPharma. Quality Assurance during Post-Merger Integration. https:\/\/www.propharmagroup.com\/thought-leadership\/giving-quality-assurance-respect-during-a-post-merger-integration<\/li>\n<li>Outsourced Pharma. Integrating Quality Processes and Documentation after a Merger. https:\/\/www.outsourcedpharma.com\/doc\/integrating-quality-processes-and-documentation-after-a-merger-0001<\/li>\n<li>Bain. Salesforce Integration Generates M&amp;A Success in Healthcare. https:\/\/www.bain.com\/client-results\/salesforce-integration-generates-m-and-a-success-in-healthcare\/<\/li>\n<li>Koerber. DSCSA enforcement update. https:\/\/koerber-supplychain.com\/about-us\/blog\/dscsa-enforcement-has-begun\/<\/li>\n<\/ul>\n<footer>\n    <a class=\"cta\" href=\"https:\/\/nmsconsulting.com\/contact\/\">Speak with a consultant<\/a><br \/>\n  <\/footer>\n<\/div>\n<\/div>\n    <\/div>\n<\/div>\n<!-- \/module text --><!-- module text -->\n<div  class=\"module module-text tb_s3lw616   \" data-lazy=\"1\">\n        <div  class=\"tb_text_wrap\">\n        <p><u><br><br><br>About the Author<\/u><\/p>    <\/div>\n<\/div>\n<!-- \/module text -->        <\/div>\n                        <\/div>\n        <\/div>\n                        <div  data-lazy=\"1\" class=\"module_row themify_builder_row tb_echs406 tf_w\">\n                        <div class=\"row_inner col_align_top tb_col_count_2 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column tb_b4m7100 first\">\n                            <\/div>\n                    <div  data-lazy=\"1\" class=\"module_column tb-column tb_4cgi000 last\">\n                            <\/div>\n                        <\/div>\n        <\/div>\n                        <div  data-lazy=\"1\" class=\"module_row themify_builder_row tb_jc06001 tf_w\">\n                        <div class=\"row_inner col_align_top tb_col_count_2 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column tb_l7sv606 first\">\n                    <!-- module image -->\n<div  class=\"module module-image tb_ew51070 image-top   tf_mw\" data-lazy=\"1\">\n        <div class=\"image-wrap tf_rel tf_mw\">\n            <a href=\"https:\/\/nmsconsulting.com\/team\/aykut-cakir\/\">\n                   <img decoding=\"async\" src=\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2021\/08\/aykut-new2-100x100.jpg\" width=\"100\" height=\"100\" class=\"wp-post-image wp-image-8025\" title=\"Aykut Cakir\" alt=\"Aykut Cakir\" srcset=\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2021\/08\/aykut-new2-100x100.jpg 100w, https:\/\/nmsconsulting.com\/wp-content\/uploads\/2021\/08\/aykut-new2-300x300.jpg 300w, https:\/\/nmsconsulting.com\/wp-content\/uploads\/2021\/08\/aykut-new2-250x250.jpg 250w, https:\/\/nmsconsulting.com\/wp-content\/uploads\/2021\/08\/aykut-new2-200x200.jpg 200w\" sizes=\"(max-width: 100px) 100vw, 100px\" \/>        <\/a>\n    \n        <\/div>\n    <!-- \/image-wrap -->\n    \n        <div class=\"image-content\">\n                    <h2 class=\"image-title\">\n                                    <a href=\"https:\/\/nmsconsulting.com\/team\/aykut-cakir\/\">\n                        Aykut Cakir                    <\/a>\n                            <\/h2>\n                    <\/div>\n    <!-- \/image-content -->\n        <\/div>\n<!-- \/module image -->        <\/div>\n                    <div  data-lazy=\"1\" class=\"module_column tb-column tb_o1iq060 last\">\n                    <!-- module text -->\n<div  class=\"module module-text tb_biwo670   \" data-lazy=\"1\">\n        <div  class=\"tb_text_wrap\">\n        <p><a href=\"https:\/\/nmsconsulting.com\/team\/aykut-cakir\">Aykut Cakir<\/a>, Senior Partner and Chief Executive Officer, has a demonstrated history in negotiations, business planning, business development. He has served as a Finance Director for gases &amp; energy, pharmaceuticals, retail, FMCG, and automotive industries. He has collaborated closely with client leadership to co-create a customized operating model tailored to the unique needs of each project segment in the region. Aykut conducted workshops focused on developing effective communication strategies to ensure team alignment with new operating models and organizational changes.\u00a0<\/p>    <\/div>\n<\/div>\n<!-- \/module text -->        <\/div>\n                        <\/div>\n        <\/div>\n        <\/div>\n<!--\/themify_builder_content-->\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Capture pharmaceutical M&#038;A integration savings across R&#038;D, manufacturing, supply chain, and SG&#038;A. KPIs, day 0 30 60 90 checklists and PMO templates.<\/p>\n","protected":false},"author":4,"featured_media":15360,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[68,22,69,425,1,435],"tags":[],"class_list":["post-15357","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corp-ad","category-insights","category-mgmt-con","category-mergers-acquisitions","category-nms","category-pharma","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharmaceutical M&amp;A Integration Savings: R&amp;D, Supply, SG&amp;A<\/title>\n<meta name=\"description\" content=\"Capture pharmaceutical M&amp;A integration savings across R&amp;D, manufacturing, supply chain, and SG&amp;A. KPIs, day 0 30 60 90 checklists and PMO templates.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmaceutical M&amp;A Integration Savings: R&amp;D, Supply, SG&amp;A\" \/>\n<meta property=\"og:description\" content=\"Capture pharmaceutical M&amp;A integration savings across R&amp;D, manufacturing, supply chain, and SG&amp;A. KPIs, day 0 30 60 90 checklists and PMO templates.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"NMS Consulting\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-16T19:50:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-17T15:18:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Arthur Mansourian\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NMSConsultingBH\" \/>\n<meta name=\"twitter:site\" content=\"@NMSConsultingBH\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arthur Mansourian\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/\"},\"author\":{\"name\":\"Arthur Mansourian\",\"@id\":\"https:\/\/nmsconsulting.com\/#\/schema\/person\/32bbbcba1bcf4b036770df81350721af\"},\"headline\":\"Pharmaceutical M&#038;A Integration Savings Playbook 2025: R&#038;D, Manufacturing, Quality, Supply Chain, Commercial and SG&#038;A\",\"datePublished\":\"2025-09-16T19:50:21+00:00\",\"dateModified\":\"2025-09-17T15:18:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/\"},\"wordCount\":869,\"publisher\":{\"@id\":\"https:\/\/nmsconsulting.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg\",\"articleSection\":[\"Corporate Advisory\",\"Insights\",\"Management Consulting\",\"Mergers &amp; Acquisitions\",\"NMS\",\"Pharma\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/\",\"url\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/\",\"name\":\"Pharmaceutical M&A Integration Savings: R&D, Supply, SG&A\",\"isPartOf\":{\"@id\":\"https:\/\/nmsconsulting.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg\",\"datePublished\":\"2025-09-16T19:50:21+00:00\",\"dateModified\":\"2025-09-17T15:18:30+00:00\",\"description\":\"Capture pharmaceutical M&A integration savings across R&D, manufacturing, supply chain, and SG&A. KPIs, day 0 30 60 90 checklists and PMO templates.\",\"breadcrumb\":{\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#primaryimage\",\"url\":\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg\",\"contentUrl\":\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg\",\"width\":1920,\"height\":1280,\"caption\":\"Pharmaceutical M&A Integration Savings Playbook 2025: R&D, Manufacturing, Quality, Supply Chain, Commercial and SG&A\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/nmsconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NMS\",\"item\":\"https:\/\/nmsconsulting.com\/nms\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pharmaceutical M&#038;A Integration Savings Playbook 2025: R&#038;D, Manufacturing, Quality, Supply Chain, Commercial and SG&#038;A\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/nmsconsulting.com\/#website\",\"url\":\"https:\/\/nmsconsulting.com\/\",\"name\":\"NMS Consulting\",\"description\":\"A Vision for Solutions\",\"publisher\":{\"@id\":\"https:\/\/nmsconsulting.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/nmsconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/nmsconsulting.com\/#organization\",\"name\":\"NMS Consulting, Inc.\",\"url\":\"https:\/\/nmsconsulting.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nmsconsulting.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2019\/03\/Logo-Full-Color-copy-cropped.png\",\"contentUrl\":\"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2019\/03\/Logo-Full-Color-copy-cropped.png\",\"width\":1920,\"height\":1612,\"caption\":\"NMS Consulting, Inc.\"},\"image\":{\"@id\":\"https:\/\/nmsconsulting.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/NMSConsultingBH\",\"https:\/\/www.instagram.com\/nmsglobal\/\",\"https:\/\/www.linkedin.com\/company\/nms-consulting-inc\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/nmsconsulting.com\/#\/schema\/person\/32bbbcba1bcf4b036770df81350721af\",\"name\":\"Arthur Mansourian\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nmsconsulting.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa34b51e194cd6f842877704f0b70bfc92606c57a35c98cd948ae6c9bbce8639?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa34b51e194cd6f842877704f0b70bfc92606c57a35c98cd948ae6c9bbce8639?s=96&d=mm&r=g\",\"caption\":\"Arthur Mansourian\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmaceutical M&A Integration Savings: R&D, Supply, SG&A","description":"Capture pharmaceutical M&A integration savings across R&D, manufacturing, supply chain, and SG&A. KPIs, day 0 30 60 90 checklists and PMO templates.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/","og_locale":"en_US","og_type":"article","og_title":"Pharmaceutical M&A Integration Savings: R&D, Supply, SG&A","og_description":"Capture pharmaceutical M&A integration savings across R&D, manufacturing, supply chain, and SG&A. KPIs, day 0 30 60 90 checklists and PMO templates.","og_url":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/","og_site_name":"NMS Consulting","article_published_time":"2025-09-16T19:50:21+00:00","article_modified_time":"2025-09-17T15:18:30+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg","type":"image\/jpeg"}],"author":"Arthur Mansourian","twitter_card":"summary_large_image","twitter_creator":"@NMSConsultingBH","twitter_site":"@NMSConsultingBH","twitter_misc":{"Written by":"Arthur Mansourian","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#article","isPartOf":{"@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/"},"author":{"name":"Arthur Mansourian","@id":"https:\/\/nmsconsulting.com\/#\/schema\/person\/32bbbcba1bcf4b036770df81350721af"},"headline":"Pharmaceutical M&#038;A Integration Savings Playbook 2025: R&#038;D, Manufacturing, Quality, Supply Chain, Commercial and SG&#038;A","datePublished":"2025-09-16T19:50:21+00:00","dateModified":"2025-09-17T15:18:30+00:00","mainEntityOfPage":{"@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/"},"wordCount":869,"publisher":{"@id":"https:\/\/nmsconsulting.com\/#organization"},"image":{"@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg","articleSection":["Corporate Advisory","Insights","Management Consulting","Mergers &amp; Acquisitions","NMS","Pharma"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/","url":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/","name":"Pharmaceutical M&A Integration Savings: R&D, Supply, SG&A","isPartOf":{"@id":"https:\/\/nmsconsulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#primaryimage"},"image":{"@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg","datePublished":"2025-09-16T19:50:21+00:00","dateModified":"2025-09-17T15:18:30+00:00","description":"Capture pharmaceutical M&A integration savings across R&D, manufacturing, supply chain, and SG&A. KPIs, day 0 30 60 90 checklists and PMO templates.","breadcrumb":{"@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#primaryimage","url":"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg","contentUrl":"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2025\/09\/Pharmaceutical-MA-Integration-Savings-Playbook-2025-RD-Manufacturing-Quality-Supply-Chain-Commercial-and-SGA.jpg","width":1920,"height":1280,"caption":"Pharmaceutical M&A Integration Savings Playbook 2025: R&D, Manufacturing, Quality, Supply Chain, Commercial and SG&A"},{"@type":"BreadcrumbList","@id":"https:\/\/nmsconsulting.com\/pharmaceutical-ma-integration-savings-playbook-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nmsconsulting.com\/"},{"@type":"ListItem","position":2,"name":"NMS","item":"https:\/\/nmsconsulting.com\/nms\/"},{"@type":"ListItem","position":3,"name":"Pharmaceutical M&#038;A Integration Savings Playbook 2025: R&#038;D, Manufacturing, Quality, Supply Chain, Commercial and SG&#038;A"}]},{"@type":"WebSite","@id":"https:\/\/nmsconsulting.com\/#website","url":"https:\/\/nmsconsulting.com\/","name":"NMS Consulting","description":"A Vision for Solutions","publisher":{"@id":"https:\/\/nmsconsulting.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nmsconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nmsconsulting.com\/#organization","name":"NMS Consulting, Inc.","url":"https:\/\/nmsconsulting.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nmsconsulting.com\/#\/schema\/logo\/image\/","url":"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2019\/03\/Logo-Full-Color-copy-cropped.png","contentUrl":"https:\/\/nmsconsulting.com\/wp-content\/uploads\/2019\/03\/Logo-Full-Color-copy-cropped.png","width":1920,"height":1612,"caption":"NMS Consulting, Inc."},"image":{"@id":"https:\/\/nmsconsulting.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NMSConsultingBH","https:\/\/www.instagram.com\/nmsglobal\/","https:\/\/www.linkedin.com\/company\/nms-consulting-inc\/"]},{"@type":"Person","@id":"https:\/\/nmsconsulting.com\/#\/schema\/person\/32bbbcba1bcf4b036770df81350721af","name":"Arthur Mansourian","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nmsconsulting.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa34b51e194cd6f842877704f0b70bfc92606c57a35c98cd948ae6c9bbce8639?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa34b51e194cd6f842877704f0b70bfc92606c57a35c98cd948ae6c9bbce8639?s=96&d=mm&r=g","caption":"Arthur Mansourian"}}]}},"_links":{"self":[{"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/posts\/15357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/comments?post=15357"}],"version-history":[{"count":10,"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/posts\/15357\/revisions"}],"predecessor-version":[{"id":15381,"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/posts\/15357\/revisions\/15381"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/media\/15360"}],"wp:attachment":[{"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/media?parent=15357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/categories?post=15357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nmsconsulting.com\/wp-json\/wp\/v2\/tags?post=15357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}